These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 4224010

  • 1. [Hepatic insufficiency and neurotropic medicinal activity].
    Ruckebusch Y, Grivel ML.
    C R Seances Soc Biol Fil; 1966; 160(4):801-6. PubMed ID: 4224010
    [No Abstract] [Full Text] [Related]

  • 2. Effects of serotonin on brain metabolism.
    Mahler DJ, Humoller FL.
    Int J Neuropsychiatry; 1967 Jun; 3(3):229-33. PubMed ID: 5298679
    [No Abstract] [Full Text] [Related]

  • 3. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM, Fischer E.
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract] [Full Text] [Related]

  • 4. The action of 5,6-dihydroxytryptamine on 5-hydroxytryptamine receptors.
    Carruba M.
    Adv Biochem Psychopharmacol; 1974 Jul; 10():103-7. PubMed ID: 4846534
    [No Abstract] [Full Text] [Related]

  • 5. Prevention by antidepressant drugs of reserpine effect on pyridine nucleotide metabolism.
    Quinn GP, Greengard P, Reid MB.
    Mol Pharmacol; 1966 Jul; 2(4):347-51. PubMed ID: 4290930
    [No Abstract] [Full Text] [Related]

  • 6. Vascular changes during oxy- and thiobarbiturate perfusion modified by reserpine and iproniazid.
    Tasker FL, De Boer B.
    Arch Int Pharmacodyn Ther; 1966 Mar; 160(1):223-30. PubMed ID: 5960123
    [No Abstract] [Full Text] [Related]

  • 7. Synergism of imipramine and desmethylimipramine with reserpine in the frog. Interaction with 5-hydroxytryptophan and 2-bromolysergid diethylamide (BOL-148).
    Lapin IP, Osipova SV, Uskova NV, Stabrovski EM.
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):37-49. PubMed ID: 5303117
    [No Abstract] [Full Text] [Related]

  • 8. Studies on Withania ashwagandha Kaul. VI. The effect of the alkaloidal fractions (acetone, alcohol and water soluble) on the central nervous system.
    Prasad S, Malhotra CL.
    Indian J Physiol Pharmacol; 1968 Oct; 12(4):175-81. PubMed ID: 5737360
    [No Abstract] [Full Text] [Related]

  • 9. [Comparison of pharmacological activity and toxicity of the antidepressants nialamide, phenelzine and iproniazide].
    Lapin IP, Samsonova ML.
    Farmakol Toksikol; 1969 Oct; 32(5):526-30. PubMed ID: 5364661
    [No Abstract] [Full Text] [Related]

  • 10. Some neuropharmacological and behavioural effects of an active fraction from Herpestis monniera, Linn (Brahmi).
    Ganguly DK, Malhtora CL.
    Indian J Physiol Pharmacol; 1967 Jan; 11(1):33-43. PubMed ID: 5630157
    [No Abstract] [Full Text] [Related]

  • 11. Potentiation of bufotenine-like syndrome induced by diethyltryptamine in reserpinized rats.
    Khazan N, Hirsch A, Sulman FG.
    Electroencephalogr Clin Neurophysiol; 1967 Jun; 22(6):589. PubMed ID: 4165027
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of reserpine-serotonin preparation on the brain and their suppression by reserpine antagonists: Iproniazid (marsilid) and LSD].
    MONNIER M, TISSOT R.
    Schweiz Arch Neurol Psychiatr; 1958 Jun; 82(1-2):218-28. PubMed ID: 13615265
    [No Abstract] [Full Text] [Related]

  • 13. Studies on the function of N-acetyl aspartic acid in brain.
    McIntosh JC, Cooper JR.
    J Neurochem; 1965 Jun; 12(9):825-35. PubMed ID: 4378895
    [No Abstract] [Full Text] [Related]

  • 14. The effects of combinations of ataraxics with hypnotics, LSD and iproniazid in the mouse.
    ASTON R, CULLUMBINE H.
    Arch Int Pharmacodyn Ther; 1960 Jun 01; 126():219-27. PubMed ID: 13794884
    [No Abstract] [Full Text] [Related]

  • 15. Further studies of the effects of psychotropic drugs on the behavior of guinea pigs and rats.
    LIBERSON WT, ELLEN P, SCHWARTZ E, WILSON A, GAGNON VP.
    J Neuropsychiatr; 1962 Jun 01; 3():298-303. PubMed ID: 14465046
    [No Abstract] [Full Text] [Related]

  • 16. Mechanism of cholinergic potentiation of tranquilizer activity.
    Saxena PN.
    Indian J Physiol Pharmacol; 1968 Jan 01; 12(1):53-7. PubMed ID: 4970598
    [No Abstract] [Full Text] [Related]

  • 17. Release of particulate norepinephrine by d-LSD-25 and reserpine.
    Sankar DV, Domjan M.
    Res Commun Chem Pathol Pharmacol; 1973 Jan 01; 5(1):205-14. PubMed ID: 4686104
    [No Abstract] [Full Text] [Related]

  • 18. Accentuation of the psychological effects of LSD-25 in normal subjects treated with reserpine.
    Resnick O, Krus DM, Raskin M.
    Life Sci; 1965 Jul 01; 4(14):1433-7. PubMed ID: 5850269
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of vagotomy and lysergic acid diethylamide (LSD) on ulcerogenic action of phenylbutazone and reserpine in rats with regard to the role of 5-hydroxytryptamine (author's transl)].
    Kohút A, Nicák A.
    Bratisl Lek Listy; 1977 Sep 01; 68(3):336-43. PubMed ID: 912454
    [No Abstract] [Full Text] [Related]

  • 20. Growth inhibition of Crithidia fasciculata by serotoninergic and adrenergic drugs.
    Blum JJ.
    J Protozool; 1969 May 01; 16(2):317-9. PubMed ID: 4389619
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.